0.4190GBP+4.49%Mkt Cap: 3.12M $P/E: —1d ago
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develo…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.12M $
Enterprise Value-1.24M $
Revenue (TTM)2.18M $
Gross Profit1.59M $
Net Income (TTM)-11.63M $
Revenue/Share0.0064 USD
Last Price0.4190 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees13
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB0033278473
Valuation
P/E (Trailing)—
P/E (Forward)-0.62
PEG—
EV/EBITDA0.11
EV/Revenue-0.57
P/S1.59
P/B0.93
EPS (TTM)-0.03
EPS (Forward)-0.01
52W Range
0.24402% of range10.50
52W High10.50 GBP
52W Low0.2440 GBP
Profitability
Gross Margin73.08%
Oper. Margin-342.88%
EBITDA Margin0.00%
Profit Margin-534.62%
ROE-323.35%
ROA-173.80%
Growth
Revenue Growth-90.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.20M $
CapEx (TTM)—
FCF Margin-287.72%
FCF Yield-200.41%
Net Debt-4.36M $
Net Debt/EBITDA0.38
Balance Sheet
Debt/Equity—
Current Ratio2.06
Quick Ratio1.86
Book Value/Sh0.0050 GBP
Cash/Share0.0060 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.581.33M
Float526.03M
Insiders12.80%
Institutions11.85%
Technical
SMA 500.4447 (-5.8%)
SMA 2000.9493 (-55.9%)
Beta0.00
S&P 52W Chg18.16%
Avg Vol (30d)4.39M
Avg Vol (10d)6.01M
Technical Indicators
RSI (14)50.7
MACD-0.0095
MACD Signal-0.0213
MACD Hist.+0.0118
BB Upper0.4614 GBP
BB Middle0.3934 GBP
BB Lower0.3254 GBP
BB Width34.58%
ATR (14)0.1090 GBP
Vol Ratio (20d)0.99x